PRME
Prime Medicine Inc
NASDAQ · Biotechnology
$3.57
+0.33 (+10.19%)
Analyst Consensus
Buy
17 analysts
Price Target
Analyst Price Target
+1,109.8% upside
Low Target
$33.60
Average Target
$43.19
High Target
$71.66
Current Price
$3.57
Current
$3.57
$3.57
Target
$43.19
$43.19
$33.60
$43.19 avg
$71.66